Summary

Zydus Wellness Limited announced robust financial results for its fourth quarter and the full financial year ended March 31, 2026. Consolidated net sales for Q4 FY26 surged by 62.1% year-on-year to ₹14,761 million, while annual net sales for FY26 grew by 46.4% year-on-year to ₹39,400 million. The company's EBITDA for Q4 FY26 increased by 34.2% to ₹5,097 million, reflecting the positive impact of post-acquisition performance. Profit After Tax for FY26 was recorded at ₹1,972 million. Key brands such as Sugar Free, Glucon-D, Everyuth, and Nycil continued to demonstrate strong performance, maintaining or strengthening their market leadership through strategic innovation, new product launches, and expanded distribution.

Key Highlights

1. 1

   Zydus Wellness Limited reported a significant consolidated net sales growth of 62.1% year-on-year for Q4 FY26, reaching ₹14,761 million.

2. 2

   For the full financial year 2026, the Company's annual net sales increased by 46.4% year-on-year to ₹39,400 million.

3. 3

   EBITDA for Q4 FY26 stood at ₹5,097 million, demonstrating a strong growth of 34.2% year-on-year, including the performance of a newly acquired business.

4. 4

   Profit After Tax (PAT) for the full financial year 2026 was reported at ₹1,972 million.

5. 5

   Sugar Free strengthened its leadership position in the sugar substitute category by achieving a 96.1% market share.

6. 6

   Glucon-D maintained its leadership with a 58.9% MAT market share and expanded into the performance hydration category.

7. 7

   Everyuth delivered strong double-digit growth in FY26, driven by innovation, distribution expansion, and enhanced consumer experience, further strengthening its market presence in facial cleansing.